Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer

Current Cancer Drug Targets

Volumn 9, Issue 8, 2009, Pages 904-914

  Bielanska, J ^a   Hernandez Losa J ^b   Perez Verdaguer M ^a   Moline, T ^b   Somoza, R ^b   Ramon Y Cajal S ^b   Condom, E ^c   Ferreres, J C ^b   Felipe, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Cancer; Human tumors; Kv1.3; Kv1.5; Potassium channels

Indexed keywords

POTASSIUM CHANNEL KV1.3; POTASSIUM CHANNEL KV1.5;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY REGIONS; CANCER TISSUE; CARCINOGENESIS; CARCINOMA; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LEUKOCYTE; PHENOTYPE; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KV1.3 POTASSIUM CHANNEL; KV1.5 POTASSIUM CHANNEL; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS;

EID: 74849087501     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800909790192400     Document Type: Article

References (50)

1. rd ed.; Sinauer: Sunderland, Mass., 2001; p xviii, 814.
2. Ashcroft, F. M. Ion Channels and Disease: Channelopathies; Academic Press: San Diego, 2000; p xxi, 481.
3. Felipe, A.; Vicente, R.; Villalonga, N.; Roura-Ferrer, M.; Martinez-Marmol, R.; Sole, L.; Ferreres, J. C.; Condom, E. Potassium channels: new targets in cancer therapy. Cancer Detect. Prev. 2006, 30, 375-385.
4. Kunzelmann, K. Ion channels and cancer. J. Membr. Biol. 2005, 205, 159-173.
5. Wonderlin, W. F.; Strobl, J. S. Potassium channels, proliferation and G1 progression. J. Membr. Biol. 1996, 154, 91-107.
6. Cahalan, M. D.; Chandy, K. G. Ion channels in the immune system as targets for immunosuppression. Curr. Opin. Biotechnol. 1997, 8, 749-756.
7. Pardo, L. A.; Contreras-Jurado, C.; Zientkowska, M.; Alves, F.; Stuhmer, W. Role of voltage-gated potassium channels in cancer. J. Membr. Biol. 2005, 205, 115-124.
8. Renaudo, A.; Watry, V.; Chassot, A. A.; Ponzio, G.; Ehrenfeld, J.; Soriani, O. Inhibition of tumor cell proliferation by sigma ligands is associated with K+ Channel inhibition and p27kip1 accumulation. J. Pharmacol. Exp. Ther. 2004, 311, 1105-1114.
9. Villalonga, N.; Martinez-Marmol, R.; Roura-Ferrer, M.; David, M.; Valenzuela, C.; Soler, C.; Felipe, A. Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation. Biochim. Biophys. Acta 2008, 1783, 728-736.
10. Conti, M. Targeting K+ channels for cancer therapy. J. Exp. Ther. Oncol. 2004, 4, 161-166.
11. Pardo, L. A. Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 2004, 19, 285-292.
12. Pardo, L. A.; del Camino, D.; Sanchez, A.; Alves, F.; Bruggemann, A.; Beckh, S.; Stuhmer, W. Oncogenic potential of EAG K(+) channels. EMBO J. 1999, 18, 5540-5547.
13. Arcangeli, A. Expression and role of hERG channels in cancer cells. Novartis Found. Symp. 2005, 266, 225-32; discussion 232-234.
14. Camacho, J. Ether a go-go potassium channels and cancer. Cancer Lett. 2006, 233, 1-9.
15. Chen, S. Z.; Jiang, M.; Zhen, Y. S. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin. Cancer Chemother. Pharmacol. 2005, 56, 212-220.
16. Crociani, O.; Guasti, L.; Balzi, M.; Becchetti, A.; Wanke, E.; Olivotto, M.; Wymore, R. S.; Arcangeli, A. Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J. Biol. Chem. 2003, 278, 2947-2955.
17. Farias, L. M.; Ocana, D. B.; Diaz, L.; Larrea, F.; Avila-Chavez, E.; Cadena, A.; Hinojosa, L. M.; Lara, G.; Villanueva, L. A.; Vargas, C.; Hernandez-Gallegos, E.; Camacho-Arroyo, I.; Duenas-Gonzalez, A.; Perez-Cardenas, E.; Pardo, L. A.; Morales, A.; Taja-Chayeb, L.; Escamilla, J.; Sanchez-Pena, C.; Camacho, J. Ether a go-go potassium channels as human cervical cancer markers. Cancer Res. 2004, 64, 6996-7001.
18. Lastraioli, E.; Taddei, A.; Messerini, L.; Comin, C. E.; Festini, M.; Giannelli, M.; Tomezzoli, A.; Paglierani, M.; Mugnai, G.; De Manzoni, G.; Bechi, P.; Arcangeli, A. hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett's esophagus. J. Cell Physiol. 2006, 209, 398-404.
19. Preussat, K.; Beetz, C.; Schrey, M.; Kraft, R.; Wolfl, S.; Kalff, R.; Patt, S. Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci. Lett. 2003, 346, 33-36.
20. Kotecha, S. A.; Schlichter, L. C. A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation. J. Neurosci. 1999, 19, 10680-10693.
21. Vicente, R.; Escalada, A.; Coma, M.; Fuster, G.; Sanchez-Tillo, E.; Lopez-Iglesias, C.; Soler, C.; Solsona, C.; Celada, A.; Felipe, A. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J. Biol. Chem. 2003, 278, 46307-46320.
22. Villalonga, N.; Escalada, A.; Vicente, R.; Sanchez-Tillo, E.; Celada, A.; Solsona, C.; Felipe, A. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages. Biochem. Biophys. Res. Commun. 2007, 352, 913-918.
23. Vicente, R.; Coma, M.; Busquets, S.; Moore-Carrasco, R.; Lopez-Soriano, F. J.; Argiles, J. M.; Felipe, A. The systemic inflammatory response is involved in the regulation of K(+) channel expression in brain via TNF-alpha-dependent and -independent pathways. FEBS Lett. 2004, 572, 189-194.
24. Vicente, R.; Escalada, A.; Villalonga, N.; Texido, L.; Roura-Ferrer, M.; Martin-Satue, M.; Lopez-Iglesias, C.; Soler, C.; Solsona, C.; Tamkun, M. M.; Felipe, A. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J. Biol. Chem. 2006, 281, 37675-37685.
25. Abdul, M.; Hoosein, N. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett. 2002, 186, 99-105.
26. Abdul, M.; Hoosein, N. Voltage-gated potassium ion channels in colon cancer. Oncol. Rep. 2002, 9, 961-964.
27. Abdul, M.; Santo, A.; Hoosein, N. Activity of potassium channel-blockers in breast cancer. Anticancer Res. 2003, 23, 3347-3351.
28. Grunnet, M.; Rasmussen, H. B.; Hay-Schmidt, A.; Klaerke, D. A. The voltage-gated potassium channel subunit, Kv1.3, is expressed in epithelia. Biochim. Biophys. Acta. 2003, 1616, 85-94.
29. Attali, B.; Wang, N.; Kolot, A.; Sobko, A.; Cherepanov, V.; Soliven, B. Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells. J. Neurosci. 1997, 17, 8234-8245.
30. Roepke, T. K.; Kontogeorgis, A.; Ovanez, C.; Xu, X.; Young, J. B.; Purtell, K.; Goldstein, P. A.; Christini, D. J.; Peters, N. S.; Akar, F. G.; Gutstein, D. E.; Lerner, D. J.; Abbott, G. W. Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f). FASEB J. 2008, 22, 3648-3660.
31. Stuhmer, W.; Alves, F.; Hartung, F.; Zientkowska, M.; Pardo, L. A. Potassium channels as tumour markers. FEBS Lett. 2006, 580, 2850-2852.
32. Tschritter, O.; Machicao, F.; Stefan, N.; Schafer, S.; Weigert, C.; Staiger, H.; Spieth, C.; Haring, H. U.; Fritsche, A. A new variant in the human Kv1.3 gene is associated with low insulin sensitivity and impaired glucose tolerance. J. Clin. Endocrinol. Metab. 2006, 91, 654-658.
33. Beeton, C.; Chandy, K. G. Potassium channels, memory T cells, and multiple sclerosis. Neuroscientist 2005, 11, 550-562.
34. Roura-Ferrer, M.; Sole, L.; Martinez-Marmol, R.; Villalonga, N.; Felipe, A. Skeletal muscle Kv7 (KCNQ) channels in myoblast differentiation and proliferation. Biochem. Biophys. Res. Commun. 2008, 369, 1094-1097.
35. Hegle, A. P.; Marble, D. D.; Wilson, G. F. A voltage-driven switch for ion-independent signaling by ether-a-go-go K+ channels. Proc. Natl. Acad. Sci. USA 2006, 103, 2886-2891.
36. Kaczmarek, L. K. Non-conducting functions of voltage-gated ion channels. Nat. Rev. Neurosci. 2006, 7, 761-771.
37. Vautier, F.; Belachew, S.; Chittajallu, R.; Gallo, V. Shaker-type potassium channel subunits differentially control oligodendrocyte progenitor proliferation. Glia 2004, 48, 337-345.
38. Beeton, C.; Wulff, H.; Standifer, N. E.; Azam, P.; Mullen, K. M.; Pennington, M. W.; Kolski-Andreaco, A.; Wei, E.; Grino, A.; Counts, D. R.; Wang, P. H.; LeeHealey, C. J.; S. Andrews, B.; Sankaranarayanan, A.; Homerick, D.; Roeck, W. W.; Tehranzadeh, J.; Stanhope, K. L.; Zimin, P.; Havel, P. J.; Griffey, S.; Knaus, H. G.; Nepom, G. T.; Gutman, G. A.; Calabresi, P. A.; Chandy, K. G. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. USA 2006, 103, 17414-17419.
39. Felipe, A.; Snyders, D. J.; Deal, K. K.; Tamkun, M. M. Influence of cloned voltage-gated K+ channel expression on alanine transport, Rb+ uptake, and cell volume. Am. J. Physiol. 1993, 265, C1230-C1238.
40. Gribble, F. M.; Ashcroft, F. M. Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues. Metabolism 2000, 49, 3-6.
41. Brevet, M.; Fucks, D.; Chatelain, D.; Regimbeau, J. M.; Delcenserie, R.; Sevestre, H.; Ouadid-Ahidouch, H. Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Pancreas 2009, 38, 649-654.
42. Brevet, M.; Haren, N.; Sevestre, H.; Merviel, P.; Ouadid-Ahidouch, H. DNA methylation of K(v)1.3 potassium channel gene promoter is associated with poorly differentiated breast adenocarcinoma. Cell Physiol. Biochem. 2009, 24, 25-32.
43. Conforti, L.; Petrovic, M.; Mohammad, D.; Lee, S.; Ma, Q.; Barone, S.; Filipovich, A. H. Hypoxia regulates expression and activity of Kv1.3 channels in T lymphocytes: a possible role in T cell proliferation. J. Immunol. 2003, 170, 695-702.
44. Vaupel, P.; Mayer, A.; Hockel, M. Tumor hypoxia and malignant progression. Methods Enzymol. 2004, 381, 335-354.
45. Bonnet, S.; Archer, S. L.; Allalunis-Turner, J.; Haromy, A.; Beaulieu, C.; Thompson, R.; Lee, C. T.; Lopaschuk, G. D.; Puttagunta, L.; Bonnet, S.; Harry, G.; Hashimoto, K.; Porter, C. J.; Andrade, M. A.; Thebaud, B.; Michelakis, E. D. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007, 11, 37-51.
46. Lan, M.; Shi, Y.; Han, Z.; Hao, Z.; Pan, Y.; Liu, N.; Guo, C.; Hong, L.; Wang, J.; Qiao, T.; Fan, D. Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol. Ther. 2005, 4, 1342-1347.
47. MacFarlane, S. N.; Sontheimer, H. Modulation of Kv1.5 currents by Src tyrosine phosphorylation: potential role in the differentiation of astrocytes. J. Neurosci. 2000, 20, 5245-5253.
48. Soliven, B.; Ma, L.; Bae, H.; Attali, B.; Sobko, A.; Iwase, T. PDGF upregulates delayed rectifier via Src family kinases and sphingosine kinase in oligodendroglial progenitors. Am. J. Physiol. Cell Physiol. 2003, 284, C85-C93.
49. Wang, Z. Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch. 2004, 448, 274-286.
50. Vigdor-Alboim, S.; Rothman, C.; Braiman, L.; Bak, A.; Langzam, L.; Yosef, O.; Sterengarz, B. B.; Nawrath, H.; Brodie, C.; Sampson, S. R. Discoordinate regulation of different K channels in cultured rat skeletal muscle by nerve growth factor. J. Neurosci. Res. 1999, 56, 275-283.